bioRxiv · 13 Nov 2026
Peptide-centric proteomics reveals molecular subtypes of sporadic Alzheimer's disease
Deanna L L Plubellh-index 15, Gennifer E. E Merrihew, Jea Park, Karynne Patterson, Josh D Smith, Chris Hsu, Christine C Wu, C Dirk Keene, Thomas J Montine, Michael J. MacCossh-index 29
Citations by database
Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.
- OpenCitations0
- Crossref0
- Europe PMC0
Citations per year
The current year is still counting.
- 2026 so far0
Abstract
Alzheimer's disease (AD) is a complex, age-related disease that continues to increase in incidence worldwide. Although some cases are caused by known pathogenic mutations, the majority of cases are sporadic, with uncertain etiology and commonly complicated by comorbid diseases. To better understand the molecular landscape of AD we constructed a unique brain sample set free from neuropathologic comorbidities. This cohort consists of autosomal dominant AD dementia, sporadic AD dementia, cognitively normal individuals with high AD neuropathologic change - a condition called resilient to AD, and cognitively normal cases with no or minimal AD neuropathologic change. Through quantitative mass spectrometry proteomics we obtain measures of peptides mapping to A-beta; and to tau, capturing differences in the histopathologic burden of disease. Correlations of these peptide abundance differences within sporadic AD dementia cases in the superior and medial temporal gyrus indicate the presence of two separate sporadic AD phenotypes. Additional differences are characterized at a peptide level between sporadic AD dementia and autosomal dominant AD dementia in the inferior parietal lobe and caudate nucleus. These findings indicate both shared and distinct molecular features in AD influenced by cause and age of onset of disease.
What the data shows
- No database records a citation yet, as is usual for a paper this new.
- Michael J. MacCoss has the highest h-index among the authors (29).
Graph
This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.
Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.
Start with
Cited by 0 papers
Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.
References (0)
What it cites, from open citation data, with Crossref's record of each.